Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.620
+0.170 (3.82%)
Jan 17, 2025, 4:00 PM EST - Market closed
Camp4 Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -51.5 | -49.29 | -44.19 |
| Depreciation & Amortization | 1.71 | 1.68 | 0.88 |
| Stock-Based Compensation | 3.87 | 2.91 | 1.38 |
| Other Operating Activities | 1.8 | 1.82 | 1.69 |
| Change in Accounts Payable | 0.87 | -1.12 | 1.33 |
| Change in Other Net Operating Assets | -2.81 | -0.15 | 0.37 |
| Operating Cash Flow | -46.06 | -44.16 | -38.54 |
| Capital Expenditures | -0.42 | -0.68 | -4.03 |
| Investing Cash Flow | -0.42 | -0.68 | -4.03 |
| Long-Term Debt Issued | - | 0.71 | - |
| Long-Term Debt Repaid | - | -0.59 | -0.09 |
| Net Debt Issued (Repaid) | -0.85 | 0.12 | -0.09 |
| Issuance of Common Stock | 0.21 | 0.19 | 0.06 |
| Financing Cash Flow | -1.46 | 0.3 | 100.16 |
| Net Cash Flow | -47.94 | -44.53 | 57.59 |
| Free Cash Flow | -46.48 | -44.83 | -42.57 |
| Free Cash Flow Margin | - | -12809.43% | - |
| Free Cash Flow Per Share | -95.86 | -113.51 | -136.31 |
| Levered Free Cash Flow | - | -30.16 | - |
| Unlevered Free Cash Flow | - | -30.16 | - |
| Change in Net Working Capital | - | 1.65 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.